Rare diseases
Investigational molecules
Locations
Phase 2 Study of PF-08634404 with Carboplatin and Etoposide in Adults with Untreated Small Cell Lung Cancer
SpainStudy of RMC-6291 with ivonescimab drug combination in patients with advanced RAS‑mutated solid tumors
SpainPhase 3 Study of Enpatoran in Patients with Active Cutaneous Lupus Erythematosus (with or without Systemic Disease)
SpainStudy of telisotuzumab adizutecan plus drug combination in adults with refractory metastatic colorectal cancer
SpainRandomized Study of INCB161734 Plus Standard Chemotherapy Drug Combination in Untreated KRAS G12D Metastatic Pancreatic Ductal Adenocarcinoma Patients
SpainSafety and Feasibility of Home Use On-Body Injection System for Subcutaneous Ocrelizumab in Adults with Multiple Sclerosis
SpainBempedoic acid in drug combination for patients with coronary artery disease without prior cardiovascular events
SpainStudy of Enfortumab Vedotin and Pembrolizumab for Bladder Preservation in Patients with Muscle‑Invasive Bladder Cancer
SpainLong‑Term Safety Study of ADX‑324 in Participants with Hereditary Angioedema (Phase 3 Extension)
SpainEffect of dapagliflozin and semaglutide on heart insulin resistance in type 2 diabetes patients
SpainSwitch maintenance with paclitaxel, ramucirumab and tislelizumab versus continued chemotherapy with tislelizumab in HER2‑negative, PD‑L1‑positive gastroesophageal cancer
SpainLong‑Term Safety Follow‑up of Ornithine Transcarbamylase Deficiency Patients Treated with ECUR‑506D and ECUR‑506A
SpainTell us about your condition – we search every trial in Europe and connect you with the right site.
